A multi-architecture study of specificity refinement and false-positive mechanism analysis in prostate MRI

2026

Read A multi-architecture study of specificity refinement and false-positive mechanism analysis in prostate MRI (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/arxiv-2606-29977.txt.

Introduction

Shu and seven colleagues study why false positives persist in AI detection of prostate cancer on MRI scans, and whether a small refinement step can cut them without losing true cancers. False alarms that look like cancer drive extra biopsies.

Working on the PI-CAI dataset and the external Prostate158 set, the team trains a lightweight refinement head on a frozen detection backbone, and repeats the analysis across five architectures. False positives turn out to sit nearer to true cancers than benign tissue in imaging contrast, reproducing in all 35 architecture comparisons. On one fold, refinement lifts case-level specificity from 0.469 to 0.549, a 17.2 percent gain, at preserved sensitivity, though results vary by fold. The authors conclude the effect is a property of the images, not a quirk of one model.

Catalog record

YEAR2026
COLLECTIONPAPERS
FORMATTXT
FILE SIZE25 KB
LICENSEhttp://creativecommons.org/licenses/by/4.0/
RIGHTSCC BY
SOURCEarXiv

Source: https://arxiv.org/abs/2606.29977

Browse the full library · About the Tower of Babel

Full text

The opening of the work, from the library's hosted text:

A multi-architecture study of specificity refinement and false-positive mechanism analysis in prostate MRI Abstract Yongbo Shu 1,2,3,4 , Kewen Chen 2 , Yifeng Yuan 1,3,4 , Zirui Xin 1,3,4 , Luo Lei 1,3,4 , Yang Yang 1,2,3,4 , Xi Chen 1,3,4,* , Aijing Luo 1,2,3,4,* (1) The Second Xiangya Hospital of Central South University, Changsha, Hunan 410011, China (2) School of Life Sciences, Central South University, Changsha, Hunan 410013, China (3) Hunan Provincial Key Laboratory of Medical Information Research (Central South University), Changsha, Hunan 410011, China (4) Hunan Provincial Clinical Medical Research Center for Cardiovascular Intelligent Medicine, Changsha, Hunan 410011, China * Corresponding authors: Xi Chen, [email protected]; Aijing Luo, [email protected] Abstract Objectives. To characterize residual false positives in prostate MRI detection, and to evaluate a lightweight post-hoc refinement head for case-level specificity. Materials and Methods. This retrospective study used PI-CAI (5-fold cross-validation) and Prostate158 (n = 158; external). A context-aware evidence head and an 89,216-parameter refinement head were trained on a frozen detection backbone; the evidence head was also trained on four further backbones (bare nnU-Net, bare U-Net, bare Mamba, MIGF-Mamba). For each false-positive region, T2-weighted, apparent-diffusion-coefficient, and high-b-value contrast ratios versus peri-lesional rings were compared against ground-truth lesions and contralateral benign regions. Results. False positives were closer to true cancers than to benign tissue in evidence and raw T2-weighted and apparent-diffusion-coefficient contrast, reproducing 35/35 across five architectures (Cohen’s d 1.10; FP/benign evidence ratio 2.38x) and 105/105 across modality-perturbation scenarios. On PI-CAI fold-0, refinement raised case-level specificity from 0.469 +/- 0.181 to 0.549 +/- 0.132 (+17.2%) at preserved sensitivity (0.943 +/- 0.021); 5-fold cross-validation showed fold-conditional behavior (9/15 observations positive; range -22% to +28%). On Prostate158, both models saturated (McNemar pooled p = 0.69), while the false-positive contrast-matching finding replicated. Conclusion. Residual false positives are contrast-matched to cancer (sharing raw imaging features rather than histologically confirmed mimicry), reproducing across five architectures – a data-level imaging property, not model-specific artifacts; post-hoc refinement adds practical specificity in-domain but is fold-conditional. Keywords: Prostate cancer; Magnetic resonance imaging; Deep learning; False positive reactions; Image interpretation, computer-assisted Key Points • Question. Why do false positives persist in prostate MRI AI, and can a lightweight post-hoc head improve case-level specificity without sensitivity loss? • Findings. False positives resembled true cancers more than benign tissue (35/35 across five architectures); a post-hoc head improved fold-0 specificity by 17.2%. Clinical Relevance Statement False positives from prostate MRI AI detectors are radiologically interpretable as cancer-resembling regions, not arbitrary model artifacts; this finding reproduces across five distinct architectures and informs how AI-flagged regions should be adjudicated. Introduction Clinically significant prostate cancer (csPCa) is diagnosed from multiparametric magnetic resonance imaging (MRI) followed by targeted biopsy of suspicious lesions. Prostate MRI-based artificial intelligence (AI) systems have advanced substantially on benchmark datasets such as PI-CAI [1], yet clinical translation is held back by high false-positive rates: regions flagged by AI often do not correspond to biopsy-confirmed cancer, triggering unnecessary follow-up imaging and biopsies [2, 3]. Existing AI pipelines are overwhelmingly tuned to maximize sensitivity, while specificity receives comparatively little attention and the nature of residual false positives is rarely characterized in a way that informs clinical action on AI output. Two gaps motivate this work. First, improving case-level specificity of a deployed AI detection model typically requires full retraining; simple post-hoc recalibration (temperature or Platt scaling) cannot alter case-level specificity beyond what threshold tuning achieves, since these methods preserve ranking. Lightweight post-hoc specificity refinement on a frozen backbone that preserves sensitivity is therefore under-explored in prostate MRI. Second, false positives are usually summarized as a single error rate; their evidence structure — whether they resemble true cancers in raw imaging contrast or are arbitrary model artifacts — is rarely disentangled. Without that distinction, recommendations for radiologist adjudication and triage remain speculative. Here we first quantify the evidence structure of residual false positives. Using a context-aware evidence head and direct raw-imaging contrast on T2-weighted and apparent-diffusion-coefficient channels, false positives from a frozen csPCa detection backbone [4] are consistently closer to true cancers than to benign prostatic tissue — a direction reproducing across PI-CAI 5-fold cross-validation, seven modality-perturbation scenarios, and five distinct backbone architectures. As an implementation this mechanism analysis explains, we introduce a lightweight (89 K-parameter) post-hoc specificity refinement head; on PI-CAI fold-0 it increases case-level specificity by 17.2% at preserved sensitivity, with 5-fold cross-validation revealing fold-conditional magnitude. We replicate both analyses on Prostate158 [5] and report what works, where center-specific effects limit the claim, and what this implies for AI-assisted prostate MRI. Materials and Methods This study analyzed de-identified multiparametric prostate MRI from two publicly available, institutionally approved cohorts (PI-CAI and Prostate158) under their respective data-use licenses; no additional institutional review board approval was required and the requirement for informed consent was waived. 3.1 Datasets This retrospective study used two public prostate multiparametric MRI datasets. The PI-CAI Public Training and Development Dataset [1] (1500 multi-vendor studies from 1476 patients across three Dutch centres; 425 biopsy-confirmed csPCa, 1075 pathology-negative) served as the primary cohort; we used the official 5-fold split, restricting method development and primary evaluation to fold-0 (1200 training / 300 validation). Prostate158 [5] (158 studies with biopsy-confirmed labels) served as the external cohort. Both datasets provide axial T2-weighted, high-b-value diffusion-weighted, and apparent-diffusion-coefficient sequences. Preprocessing — axial resampling to 0.5 × 0.5 × 3.0 mm, gland-centered cropping to 128 × 128 × 32 voxels, and per-channel normalization — followed our prior work [4] and was identical across datasets. 3.2 Frozen detection backbone All experiments used a frozen multi-modal csPCa detection backbone from our earlier work [4]. The backbone accepts three co-registered channels (T2-weighted, high-b-value DWI, ADC) at 128 × 128 × 32 voxels; each modality has its own four-level encoder (3 × 3 × 3 convolution, downsampling 2 per level). Adaptive gating fuses encoders at the lowest-resolution stage and feeds a shared three-stage decoder with dec1, dec2, dec3 outputs at 32/64/128 channels and full/half/quarter resolution; a 1 × 1 × 1 convolution returns per-voxel logits. Each input channel was zeroed with probability 0.3 per sample during backbone training; dropout was disabled at inference. We reused five-seed checkpoints (42, 123, 456, 789, 1024) for the A2 variant (gating + modality dropout, without deep supervision) unchanged. We selected this backbone for three reasons: (i) modality isolation via per-modality encoders enables deterministic per-channel attribution required by the evidence-grounded analyses in §3.4; (ii) clinical-grade efficiency with 9.45 M parameters and 8.5 ms single-volume inference latency leaves compute headroom for downstream uncertainty and risk-stratification pipelines; (iii) measurable-gain headroom since the A2 variant’s 5-fold mean case-level specificity (0.46) avoids ceiling effects that would compress observable post-hoc refinement gains. 3.3 Post-hoc specificity refinement head (P2a) The refinement head takes the backbone’s decoder features at three resolutions (dec1/dec2/dec3; 32/64/128 channels). The dec2 and dec3 streams are projected to 32 channels and trilinearly upsampled to dec1; the three streams are concatenated (96 channels), passed through a 3 × 3 × 3 convolution, instance normalization, and ReLU, then projected to a 2-channel per-voxel logit residual via a 1 × 1 × 1 convolution (initialized at zero; 89,216 trainable parameters). The residual is added to the backbone’s final-stage logits before softmax. The head was trained for 100 epochs with Adam (learning rate 1 × 10⁻⁴,

Read the complete text